Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Neurocrine Bioscienc (NBIX)

Neurocrine Bioscienc (NBIX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,496,781
  • Shares Outstanding, K 93,255
  • Annual Sales, $ 788,090 K
  • Annual Income, $ 37,010 K
  • 60-Month Beta 1.30
  • Price/Sales 13.62
  • Price/Cash Flow 168.81
  • Price/Book 12.91

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate 0.22
  • Number of Estimates 11
  • High Estimate 0.91
  • Low Estimate -0.65
  • Prior Year 0.79
  • Growth Rate Est. (year over year) -72.15%

Price Performance

See More
Period Period Low Period High Performance
1-Month
109.22 +3.47%
on 08/11/20
136.26 -17.06%
on 07/20/20
-16.68 (-12.86%)
since 07/10/20
3-Month
109.22 +3.47%
on 08/11/20
136.26 -17.07%
on 07/09/20
-0.56 (-0.49%)
since 05/11/20
52-Week
72.14 +56.65%
on 03/18/20
136.26 -17.07%
on 07/09/20
+17.51 (+18.34%)
since 08/09/19

Most Recent Stories

More News
Watch for Neurocrine Biosc to Potentially Rebound After Falling 1.59% Yesterday

Neurocrine Biosc (NASDAQ:NBIX) traded in a range yesterday that spanned from a low of $118.02 to a high of $120.87. Yesterday, the shares fell 1.6%, which took the trading range below the 3-day low of...

NBIX : 113.01 (+0.40%)
NASDAQ Rises for Fifth Straight Day and Logs Another New High

NASDAQ Rises for Fifth Straight Day and Logs Another New High

BGS : 28.81 (-1.57%)
THS : 43.33 (+2.43%)
NBIX : 113.01 (+0.40%)
AVXL : 3.92 (-0.76%)
XPO : 84.00 (+2.79%)
TWTR : 37.28 (-0.43%)
DBD : 8.50 (+2.66%)
DIS : 130.49 (+1.32%)
Neurocrine Biosciences (NBIX) Surpasses Q2 Earnings and Revenue Estimates

Neurocrine (NBIX) delivered earnings and revenue surprises of 24.62% and 18.28%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

NBIX : 113.01 (+0.40%)
Neurocrine: 2Q Earnings Snapshot

SAN DIEGO (AP) _ Neurocrine Biosciences Inc. (NBIX) on Monday reported second-quarter earnings of $79.6 million.

NBIX : 113.01 (+0.40%)
Neurocrine Biosciences Reports Second Quarter 2020 Financial Results

, /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced its financial results for the second quarter ended and provided revised full-year 2020 financial expense guidance.

NBIX : 113.01 (+0.40%)
Neurocrine Biosciences to Participate at the William Blair Biotech Focus Conference 2020

, /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will participate at the William Blair Biotech Focus Conference 2020 at , August 6, 2020. , Chief Business Development and Strategy Officer,...

NBIX : 113.01 (+0.40%)
After Yesterday's Decline of 1.79%, Neurocrine Biosc Offers Investors Better Value

Neurocrine Biosc (NASDAQ:NBIX) traded in a range yesterday that spanned from a low of $124.27 to a high of $127.19. Yesterday, the shares fell 1.8%, which took the trading range below the 3-day low of...

NBIX : 113.01 (+0.40%)
Zacks.com featured highlights include: MarketAxess, Domino's Pizza and Neurocrine Biosciences

Zacks.com featured highlights include: MarketAxess, Domino's Pizza and Neurocrine Biosciences

DPZ : 388.65 (+0.70%)
NBIX : 113.01 (+0.40%)
MKTX : 482.79 (+0.02%)
3 Stocks With Momentum Anomaly to Buy This Earnings Season

These frontrunners are currently witnessing a short-term pullback in price. So make sure you're taking full advantage of the opportunity.

DPZ : 388.65 (+0.70%)
NBIX : 113.01 (+0.40%)
MKTX : 482.79 (+0.02%)
57.7% Return Seen to Date on SmarTrend Neurocrine Biosc Call (NBIX)

SmarTrend identified an Uptrend for Neurocrine Biosc (NASDAQ:NBIX) on March 24th, 2020 at $83.74. In approximately 4 months, Neurocrine Biosc has returned 57.73% as of today's recent price of $132.09....

NBIX : 113.01 (+0.40%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade NBIX with:

Business Summary

Neurocrine Biosciences is a neuroscience-based company focused on the discovery and development of novel therapeutics for neuropsychiatric, neuroinflammatory and neurodegenerative diseases and disorders. The company's neuroscience, endocrine and immunology disciplines provide a unique biological understanding...

See More

Key Turning Points

2nd Resistance Point 116.62
1st Resistance Point 114.81
Last Price 113.01
1st Support Level 110.21
2nd Support Level 107.42

See More

52-Week High 136.26
Last Price 113.01
Fibonacci 61.8% 111.77
Fibonacci 50% 104.20
Fibonacci 38.2% 96.64
52-Week Low 72.14

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar